Biofrontera (BFRI) Current Leases (2022 - 2025)

Biofrontera's (BFRI) quarterly Current Leases came in at $332000.0 in Q4 2025, down 39.42% year-on-year from $548000.0 in Q4 2024, and up 8.14% quarter-over-quarter from $307000.0 in Q3 2025.

Biofrontera (BFRI) Current Leases (2022 - 2025) Analysis & Trends

Biofrontera's Current Leases history runs 4 years deep, the most recent figure standing at $332000.0 for Q4 2025.

  • On a quarterly basis, Current Leases fell 39.42% year-over-year to $332000.0 in Q4 2025; TTM through Dec 2025 was $332000.0, a 39.42% decrease from a year earlier, with the FY2025 full-year figure at $332000.0, down 39.42% from the prior year.
  • Current Leases grew to $332000.0 in Q4 2025 per BFRI's latest filing, from $307000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $701000.0 in Q2 2024 and bottomed at $307000.0 in Q3 2025.
  • The 4-year median for Current Leases is $523000.0 (2022), against an average of $528750.0.
  • Across the five-year window, Current Leases soared 42.56% in 2024 and sank 54.18% in 2025, its largest moves.
  • Year by year, Current Leases stood at $498000.0 in 2022, then jumped by 38.76% to $691000.0 in 2023, then decreased by 20.69% to $548000.0 in 2024, then slumped by 39.42% to $332000.0 in 2025.
  • Per Business Quant, the three latest BFRI Current Leases figures stand at $332000.0 (Q4 2025), $307000.0 (Q3 2025), and $443000.0 (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Biofrontera 12.70 Mn 6.29 Mn 14.09 Mn 332,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 332,000.00
Sep 30, 2025 307,000.00
Jun 30, 2025 443,000.00
Mar 31, 2025 426,000.00
Dec 31, 2024 548,000.00
Sep 30, 2024 670,000.00
Jun 30, 2024 701,000.00
Mar 31, 2024 690,000.00
Dec 31, 2023 691,000.00
Sep 30, 2023 555,000.00
Mar 31, 2023 484,000.00
Dec 31, 2022 498,000.00